Rex Health Ventures — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Arrivo Bio develops novel, disease-modifying medicines targeting the root cause of hard-to-treat diseases for which few effective treatment options exist.
BiotechMedical DevicesMorrisville, US
Karen Adams(Executive Officer)Stephen E. Butts(Executive Officer)
Co-investorsOrlando Health VenturesSolas BioVentures
Censinet provides risk management solutions for healthcare organizations, built by former healthcare operators and security experts who understand the integrated risks healthcare systems face.
CybersecurityEnterprise SoftwareHealthtechSaaSBoston, US
Ed Gaudet(Founder)inCambrey Warein
Co-investorsBallad VenturesExcelerate Health VenturesHLM Venture PartnersMemorialCare Innovation FundSchooner CapitalExcel Venture Management+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.







